Cytokinetics Stock Target Price and Analyst Consensus
| CYTK Stock | USD 65.57 0.72 1.09% |
The current analyst and expert consensus on Cytokinetics is Strong Buy with 9 buy recommendations. The current projected Cytokinetics target price consensus is 62.27, with 20 analyst opinions. The most common way Cytokinetics analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Cytokinetics executives, vendors, and/or customers. Cytokinetics buy-or-sell recommendation module provides average expert sentiment on the projected Cytokinetics target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
Lowest Forecast 56.67 | Highest Forecast 69.12 | Target Price 62.27 |
Cytokinetics |
It's important to approach Cytokinetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Cytokinetics price targets
Cytokinetics' stock target price is an estimate of its future price, usually made by analysts. Using Cytokinetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Cytokinetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cytokinetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Cytokinetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cytokinetics is a key component of Cytokinetics valuation and have some predictive power on the future returns of a Cytokinetics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Momentum Invested few shares | |
 | Hedge Favorites Invested over 70 shares | |
 | Driverless Cars Invested over 200 shares | |
Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cytokinetics Stock analysis
When running Cytokinetics' price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
The data published in Cytokinetics' official financial statements usually reflect Cytokinetics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cytokinetics. For example, before you start analyzing numbers published by Cytokinetics accountants, it's critical to develop an understanding of what Cytokinetics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Cytokinetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cytokinetics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cytokinetics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cytokinetics. Please utilize our Beneish M Score to check the likelihood of Cytokinetics' management manipulating its earnings.